Purpose: Injectable collagenase Clostridium histolyticum has been an effective and well-tolerated nonsurgical treatment option for the management of Dupuytren contracture of the hand. The purpose of this study was to determine the efficacy of collagenase injection and adverse event rate in patients who had undergone previous collagenase treatment.
Methods: A retrospective chart review was performed on 332 patients treated with collagenase injection for Dupuytren contracture by three fellowship-trained hand surgeons at a single institution from 2009 to 2019. Fifty-nine joints in 45 patients underwent repeat collagenase therapy for recurrent contracture in the same digit. Pretreatment and posttreatment total metacarpophalangeal and proximal interphalangeal joint flexion contractures were recorded, with complete correction defined as <5° residual digital flexion contracture. Postmanipulation skin tears and adverse events were recorded. A comparison was made between average contracture improvement after initial collagenase injection and that after repeat injection.
Results: Forty-five patients with an average duration of 30 months (range, 6-73 months) between initial and repeat collagenase therapies were identified. The mean improvement after first collagenase injection was 45° ± 24° (39° for metacarpophalangeal joint and 50° for proximal interphalangeal joint) compared with a mean improvement of 43° ± 23° (41° for metacarpophalangeal joint and 44° for proximal interphalangeal joint) after second injection. Although similar complete correction rates and skin tear rates (32.2 % for initial and 30.5% for repeat) were observed between initial (80%) and repeat injections (73%), the occurrence of adverse events was 3 times higher (3.4% for initial and 10.2% for repeat) in the latter group.
Conclusions: Collagenase treatment of Dupuytren contracture yields effective total flexion contracture correction. Repeat collagenase treatment of previously treated digits yields similar deformity correction and complete correction rates but a higher incidence of adverse events.
Type Of Study/level Of Evidence: Therapeutic IV.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jhsa.2023.03.026 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Adjuvant steroid to percutaneous needle fasciotomy for Dupuytren's contracture. An RCT study protocol.
Dan Med J
November 2024
Department of Clinical Medicine, Aarhus University.
Introduction: Percutaneous needle fasciotomy (PNF) is a non-invasive treatment option for finger flexion contractures caused by Dupuytren's disease. Variations in PNF techniques include the use of corticosteroid injection. In the presented randomised controlled trial, we compare the efficacy of PNF +/- corticosteroid injection in terms of reducing the recurrence rate.
View Article and Find Full Text PDFDupuytren's Contracture: A Review of the Literature.
Cureus
December 2024
Department of Orthopedics, Liverpool University Hospitals National Health Service (NHS) Foundation Trust, Liverpool, GBR.
Dupuytren's contracture is a chronic condition that affects the palmar fascia, leading to progressive flexion of the fingers, particularly the ring and little fingers. This article provides an in-depth review of the current understanding of the condition and its management. Commonly seen in older men of Northern European descent, Dupuytren's can significantly impair hand function as contractures develop.
View Article and Find Full Text PDFRecurrent Refractory Non-Dupuytren Contracture in Females After Limited Fasciectomy.
Cureus
December 2024
Department of Orthopaedics, Niigata Hand Surgery Foundation, Seiro-machi, JPN.
Article Synopsis
- Non-Dupuytren's contracture, often resulting from trauma or surgery, usually doesn't need surgery; however, in this case, an 81-year-old woman had a series of surgeries for finger issues, leading to ongoing complications.
- During her surgeries, procedures like limited fasciectomy, flexor tenolysis, and joint mobilization were performed, but the flexion contracture persisted after initial attempts.
- Ultimately, despite multiple interventions including excision of the cord and attempts to improve motion, the flexion contracture recurred, highlighting the need to anticipate potential recurrence in surgical planning for non-Dupuytren's contracture.
Understanding Stakeholder Priorities in Dupuytren Disease: A Qualitative Study.
Hand (N Y)
December 2024
Department of Surgery, Division of Plastic Surgery, McMaster University, Hamilton, ON, Canada.
Background: Currently, there is no recommended standard set of outcomes to report in Dupuytren disease treatment studies, nor are there guidelines on how the outcomes themselves should be reported. This study aimed to elicit the most salient issues for patients living with and undergoing treatment for Dupuytren disease, as well as for the hand surgeons, occupational therapists, and physical therapists caring for these patients.
Methods: A qualitative, interpretive description study employing one-on-one semi-structured interviews was conducted.
Discussion: Frequency and Reporting of Complications after Dupuytren Contracture Interventions: A Systematic Review and Meta-Analysis.
Plast Reconstr Surg
January 2025
From the Division of Plastic and Reconstructive Surgery, Emory University School of Medicine.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!